SOHM launches 26 branded generic pharmaceutical products in India

SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today the launch of 26 branded generic pharmaceutical products in India. The Company has already appointed two distributors in Northern India covering the largest state of India with a population of almost 1.5 billion people. Considering the coming winter period, the Company has included two powerful and highly consumed antibiotics for respiratory diseases. The product launch also includes anti-colds, anti-asthmatics, and cough suppressant products. These products will be manufactured by the Company's facilities in India with immediate market response and penetration expected.

Utter Pradesh, India's largest state, always experiences severe cold and continuous fog in the months from November through February. There is a tremendous need for SOHM's antibiotics, anti-colds, anti-asthmatics, and cough suppressant products during these months. In addition to the two distributors in Northern India, SOHM is in negotiations with two more distributors to introduce the Company's generic drugs to the eastern part of India.

Nitin Shah, Vice President of Marketing at SOHM India, stated, "Uttar Pradesh, Bihar, and India's North Eastern States always have a strong winter season with massive consumption of anti-cold and cough suppressants. This a major market niche for SOHM to capture a large part of the consumption of these products in this area."

"The domestic pharmaceutical market in India continues to grow and is currently over $10 billion in annual sales. Keeping this in mind and accounting for our progress in generic pharmaceutical product development and marketing initiatives is very encouraging," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "The launch of our latest 26 products demonstrates SOHM's commitment to expanding the range and depth or our product lines while continuing to offer pricing advantages to our customers. We are confident in our future growth prospects as we continue to expand our product lines and attract new sales channels."

SOURCE: SOHM, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New biomarkers offer hope for early detection and prevention of Alzheimer's